Your session is about to expire
← Back to Search
Bevacizumab + Interleukin-2 for Kidney Cancer
Study Summary
This trial is studying bevacizumab and interleukin-2 in treating patients with metastatic kidney cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- It's been over 4 weeks since my last surgery or radiation, and I've recovered.I have not had any treatment for kidney cancer that has spread.I have never been treated with bevacizumab or interleukin-2.I haven't taken steroids in the last 2 weeks.I haven't had major surgery or an open biopsy in the last 28 days.I haven't had minor surgeries or biopsies in the last week, except for a central venous catheter placement.My kidney function is normal, based on creatinine levels or clearance.I am not taking steroids or other drugs that weaken my immune system.My kidney cancer is confirmed and mainly consists of clear cells.I am mostly self-sufficient and active.My hemoglobin level is at least 9 g/dL.I have never had bleeding caused by my tumor.I have never had cancer spread to my brain.My heart is healthy and I haven't had recent serious heart issues.I don't have a history of serious bleeding or blood clotting disorders.I have not received any organ transplants.I do not have inflammatory bowel disease or any serious autoimmune condition.I am not scheduled for any major surgery.I have not had a serious injury in the last 28 days.I do not have any serious, nonhealing wounds or broken bones.I am not currently experiencing any bleeding.I don't have a history of serious bleeding or blood clotting disorders.I have never had deep vein clots, significant blood vessel issues, or other clotting events.I am over 50 or have a history of lung issues or smoking, and need a lung function test.I have never had a stroke or a mini-stroke.I haven't had any cancer in the past 5 years, except for skin cancer or early-stage cervical, bladder, or breast cancer.I have been cancer-free from another type of invasive cancer for over 5 years.I don't have any major health issues like uncontrolled diabetes or infections.I have thyroiditis or rheumatoid arthritis.I haven't had any major abdominal issues like a fistula, perforation, or abscess in the last 6 months.My blood pressure is under 150/100 mm Hg.I have never had deep vein clots or significant blood vessel issues.My cancer can be measured by tests.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any documented side effects of this treatment?
"While there is some evidence that this intervention may be safe, as it is only a Phase 2 trial, there is currently no data supporting its efficacy. Therefore, our team has given it a score of 2."
Are there any available vacancies for volunteers in this clinical trial?
"No, this particular study is not looking for new patients at the moment. However, it's worth noting that there are 432 other trials currently recruiting. The original posting date was September 1st, 2005 and the most recent update was on January 9th, 2014 according to clinicaltrials.gov"
Could you please list the hospitals where this trial is taking place?
"Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center in Lebanon, UPMC Cancer Centers in Pittsburgh, and University of Virginia Cancer Center in Charlottesville are all participating in this trial. Including these locations, 11 medical centres are taking part."
Share this study with friends
Copy Link
Messenger